Linical was established in June 2005 by a group of professionals who were engaged in new drug development at a major Japanese pharmaceutical company. Ever since, in accordance with our philosophy of contributing to new drug development and promoting the happiness of patients, we have supported the clinical development efforts of pharmaceutical companies, focusing mainly on oncology, central nervous system (CNS), and immune system diseases, areas for which new drug development is sorely needed. Given the increasing internationalization of large scale pharmaceutical product development, Linical has actively expanded its activities around the world, to become the first Japanese Headquartered Global CRO (Contract Research Organization) capable of delivering a one-stop service for large-scale, global projects. As a strategic business partner, we can offer a streamlined service with comprehensive support, ranging from innovative drug development and clinical development to post-marketing surveillance and clinical research for supporting the drug life cycle management.
